- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (410)
4 result(s) found for: Fun.
Displaying page 1 of 1.
| EudraCT Number: 2017-002194-18 | Sponsor Protocol Number: CA209-9P9 | Start Date*: 2018-03-15 | ||||||||||||||||
| Sponsor Name:Medical Center - University of Freiburg | ||||||||||||||||||
| Full Title: Phase 1/2 Trial to determine the Response Rate of Nivolumab in Acute Myeloid Leukemia (AML) relapse after Allogeneic Hematopoietic Cell Transplantation (allo-HCT) | ||||||||||||||||||
| Medical condition: Acute myeloid leukemia relapse after allo-HCT | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2021-002701-94 | Sponsor Protocol Number: FUN-PIR-2020-01 | Start Date*: 2021-08-13 | ||||||||||||||||
| Sponsor Name:Fundación para la Gestión de la Investigación Biomédica de Cádiz | ||||||||||||||||||
| Full Title: Pirfenidone for the reduction of pulmonary inflammatory and fibrogenic activity in patients with silicosis due to artificial stone and progressive massive fibrosis. | ||||||||||||||||||
| Medical condition: progressive massive fibrosis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2016-004793-17 | Sponsor Protocol Number: 402-C-1302 | Start Date*: 2017-05-03 | |||||||||||
| Sponsor Name:Reata Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension | |||||||||||||
| Medical condition: Pulmonary Hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) GB (Prematurely Ended) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003204-13 | Sponsor Protocol Number: 74527 | Start Date*: 2021-11-15 |
| Sponsor Name:Radboudumc | ||
| Full Title: Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Candidemia | ||
| Medical condition: Candidemia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) DE (Trial now transitioned) GR (Trial now transitioned) RO (Trial now transitioned) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.